Search Within

Eric Smith

Formats
  1. Meeting Abstract (42)
  2. Journal Article (27)
  3. Book Section (3)
  4. Research Letter (2)
  5. Guidelines (1)
  6. Review (1)
Groups
  1. Center for Hematologic Malignancies (76)
  2. Department of Medicine (76)
  3. Hematologic Malignancies Research (76)
  4. Hematologic Malignancies, Division of (76)
  5. Myeloma (76)
  6. Survivorship Research (48)

More Groups

People
  1. Sham Mailankody (44)
  2. Carl Landgren (42)
  3. Alexander Lesokhin (38)
  4. Sergio Giralt (38)
  5. Hani Hassoun (36)
  6. Neha Korde (36)

More People

Years
  1. 2025 (1)
  2. 2022 (2)
  3. 2021 (5)
  4. 2020 (13)
  5. 2019 (19)
  6. 2018 (15)

More Years

Publications
  1. Blood (27)
  2. Biology of Blood and Marrow Transplantation (8)
  3. Clinical Lymphoma, Myeloma and Leukemia (7)
  4. Journal of Clinical Oncology (4)
  5. Pocket Oncology (3)
  6. Blood Cancer Discovery (2)

More Publications

Publishers
  1. American Society of Hematology (28)
  2. Elsevier Inc. (16)
  3. Nature Publishing Group (5)
  4. American Association for Cancer Research (4)
  5. American Society of Clinical Oncology (4)
  6. Wolters Kluwer Health | Lippincott Williams & Wilkins (3)

More Publishers

Results (76)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Optimal dual-targeted CAR construct simultaneously targeting BCMA and GPRC5D prevents BCMA-escape driven relapse in multiple myeloma
    Meeting Abstract

    Fernandez de Larrea, C.; Staehr, M.; Lopez, A.; Chen, Y.; Purdon, T. J.; Ng, K. Y.; Wendel, H.; Brentjens, R. J.; Smith, E. L.
    Blood (2019)

    Fulltext@MSK | Save
  • Depth of response and outcomes by initial therapy prior to autologous hematopoietic stem cell transplantation for multiple myeloma
    Meeting Abstract

    Shah, G.; Chung, D.; Scordo, M.; Seier, K.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lesokhin, A.; Mailankody, S.; Shah, U.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Practice patterns with focal progression on daratumumab therapy
    Meeting Abstract

    Bal, S.; Peterson, T.; Landau, H.; Chung, D.; Giralt, S.; Korde, N.; Mailankody, S.; Smith, E.; Shah, U.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Stem cell mobilization and autograft purity with novel induction regimens in multiple myeloma
    Meeting Abstract

    Bal, S.; Landau, H.; Shah, G.; Scordo, M.; Dahi, P.; Lahoud, O.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lesokhin, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Ixazomib and dexamethasone in high risk smoldering multiple myeloma: A clinical and correlative pilot study
    Meeting Abstract

    Mailankody, S.; Salcedo, M.; Tavitian, E.; Korde, N.; Lendvai, N.; Hassoun, H.; Lesokhin, A. M.; Lahoud, O. B.; Smith, E. L.; Hultcrantz, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Using MALDI-TOF mass spectrometry for tracking of minimal residual disease in peripheral blood from patients with multiple myeloma
    Meeting Abstract

    Eveillard, M.; Rustad, E.; Roshal, M.; Zhang, Y.; Ciardiello, A.; Korde, N.; Hultcrantz, M.; Hassoun, H.; Smith, E. L.; Lesokhin, A. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Resource utilization within 30 days of car T cells for hematologic malignancies
    Meeting Abstract

    Shah, G.; Park, J.; Sauter, C.; Duck, E.; Halton, E.; Batlevi, C.; Palomba, M. L.; Younes, A.; Geyer, M.; Smith, E.; more...
    Value in Health (2019)

    Fulltext@MSK | Save
  • BCMA-targeted CAR T-cell therapy plus radiotherapy for the treatment of refractory myeloma reveals potential synergy
    Journal Article

    Smith, E. L.; Mailankody, S.; Staehr, M.; Wang, X.; Senechal, B.; Purdon, T. J.; Daniyan, A. F.; Geyer, M. B.; Goldberg, A. D.; Mead, E.; more...
    Cancer Immunology Research (2019)

    Fulltext@MSK | Save
  • Multiple myeloma, targeting B-cell maturation antigen with chimeric antigen receptor T-cells
    Review

    Shah, U. A.; Smith, E. L.
    The Cancer Journal (2019)

    Fulltext@MSK | Save
  • GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells
    Journal Article

    Smith, E. L.; Harrington, K.; Staehr, M.; Masakayan, R.; Jones, J.; Long, T. J.; Ng, K. Y.; Ghoddusi, M.; Purdon, T. J.; Wang, X.; more...
    Science Translational Medicine (2019)

    Fulltext@MSK | Save